menu
    • menu

    Find Avanafil manufacturers, exporters & distributors on PharmaCompass

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    20

    API Suppliers

    API Suppliers

    5

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    2

    EU WC

    EU WC

    1

    KDMF

    KDMF

    3

    NDC API

    NDC API

    0

    VMF

    NDC API

    15

    Listed Suppliers

    Other Suppliers

    4INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    27

    Others

    FINISHED DOSAGE FORMULATIONS

    18

    FDF Dossiers

    FDF Dossiers

    6

    FDA Orange Book

    FDA (Orange Book)

    5

    Europe

    Europe

    0

    Canada

    Canada

    3

    Australia

    Australia

    0

    South Africa

    South Africa

    4

    Listed Dossiers

    Listed Dossiers

    8DRUGS IN DEVELOPMENT

    FDF DossiersDRUG PRODUCT COMPOSITIONS

    57RELATED EXCIPIENT COMPANIES

    106EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    3

    US Patents

    3

    US Exclusivities

    0

    Health Canada Patents

    API REF. PRICE (USD/KG)

    $
    $ 2,201

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    NA

    Regulatory FDF Prices

    Listed Dossiers
    API/FDF Prices: Book a Demo to
    explore the features and consider
    upgrading later

    MARKET PLACE

    6

    API

    0

    FDF

    DIGITAL CONTENT

    1

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    24

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 330784-47-9, Stendra, Spedra, Ta 1790, Ta-1790, (s)-4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-n-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
    Molecular Formula
    C23H26ClN7O3
    Molecular Weight
    483.9  g/mol
    InChI Key
    WEAJZXNPAWBCOA-INIZCTEOSA-N
    FDA UNII
    DR5S136IVO
    Avanafil
    Avanafil is an orally available phosphodiesterase type 5 (PDE5) inhibitor with vasodilatory activity. Avanafil selectively inhibits PDE5, thus inhibiting the degradation of cyclic guanosine monophosphate (cGMP) found in the smooth muscle of the corpus cavernosa of the penis. The inhibition of cGMP degradation results in prolonged muscle relaxation, vasodilation, and blood engorgement of the corpus cavernosa, thereby prolonging penile erection.
    Avanafil is a Phosphodiesterase 5 Inhibitor. The mechanism of action of avanafil is as a Phosphodiesterase 5 Inhibitor.
    1 2D Structure

    Avanafil

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-[(3-chloro-4-methoxyphenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
    2.1.2 InChI
    InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1
    2.1.3 InChI Key
    WEAJZXNPAWBCOA-INIZCTEOSA-N
    2.1.4 Canonical SMILES
    COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCCC4CO)Cl
    2.1.5 Isomeric SMILES
    COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCC[C@H]4CO)Cl
    2.2 Other Identifiers
    2.2.1 UNII
    DR5S136IVO
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)-1-pyrrolidinyl)-n-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide

    2. Stendra

    2.3.2 Depositor-Supplied Synonyms

    1. 330784-47-9

    2. Stendra

    3. Spedra

    4. Ta 1790

    5. Ta-1790

    6. (s)-4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-n-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide

    7. Chebi:66876

    8. Dr5s136ivo

    9. (s)-2-(2-hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[(2-pyrimidinylmethyl)carbamoyl]pyrimidine

    10. (s)-4-(3-chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-n-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide

    11. (s)-4-[(3-chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-n-(2pyrimidinylmethyl)-5-pyrimidinecarboxamide

    12. 4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]-n-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide

    13. 4-[(3-chloro-4-methoxyphenyl)methylamino]-2-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]-n-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide

    14. 4-((3-chloro-4-methoxybenzyl)amino)-2-((2s)-2-(hydroxymethyl)pyrrolidin-1-yl)-n-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide

    15. 5-pyrimidinecarboxamide, 4-(((3-chloro-4-methoxyphenyl)methyl)amino)-2-((2s)-2-(hydroxymethyl)-1-pyrrolidinyl)-n-(2-pyrimidinylmethyl)-

    16. Stendra (tn)

    17. Avanafil [usan:inn]

    18. Unii-dr5s136ivo

    19. Zepeed

    20. Ine-5-carboxamide

    21. Spedra (tn)

    22. Avanafil [usan]

    23. Avanafil (usan/inn)

    24. Avanafil [inn]

    25. Avanafil [mi]

    26. Avanafil [vandf]

    27. Avanafil [mart.]

    28. Avanafil [who-dd]

    29. Avanafil 100 Microg/ml In Acetonitrile:dimethylsulfoxide

    30. Schembl118799

    31. Avanafil [orange Book]

    32. Gtpl7448

    33. Chembl1963681

    34. Amy1794

    35. Dtxsid50186727

    36. 4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)-1-pyrrolidinyl)-n-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide

    37. Bdbm50036629

    38. Cs1566

    39. Mfcd11977961

    40. S4019

    41. Ta1790

    42. Zinc11677857

    43. Akos024462448

    44. Ccg-229896

    45. Db06237

    46. Vi-0162

    47. Ncgc00386241-01

    48. As-20106

    49. Hy-18252

    50. Sw219217-1

    51. D03217

    52. Ab01565827_02

    53. J-019006

    54. Q2873270

    55. Brd-k65781196-001-01-4

    56. (s)-2-(2-hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[n-(2-pyrimidylmethyl)carbamoyl]-pyrimidine

    57. (s)-4-[(3-chlor-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1- Pyrrolidinyl]-n-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamid

    58. 4-[(3-chloranyl-4-methoxy-phenyl)methylamino]-2-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]-n-(pyrimidin-2-ylmethyl)pyrimid

    59. 4-[(3-chloranyl-4-methoxy-phenyl)methylamino]-2-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]-n-(pyrimidin-2-ylmethyl)pyrimid Ine-5-carboxamide

    60. Avanafil; (s)-4-chloro-6-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-n-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide

    61. E6l

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 483.9 g/mol
    Molecular Formula C23H26ClN7O3
    XLogP32.6
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count9
    Rotatable Bond Count9
    Exact Mass483.1785654 g/mol
    Monoisotopic Mass483.1785654 g/mol
    Topological Polar Surface Area125 Ų
    Heavy Atom Count34
    Formal Charge0
    Complexity642
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameStendra
    PubMed HealthAvanafil (By mouth)
    Drug ClassesErectile Dysfunction Agent
    Drug LabelSTENDRA (avanafil) is a selective inhibitor of cGMP-specific PDE5.Avanafil is designated chemically as (S)-4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide and has the following...
    Active IngredientAvanafil
    Dosage FormTablet
    RouteOral
    Strength200mg; 100mg; 50mg
    Market StatusPrescription
    CompanyVivus

    2 of 2  
    Drug NameStendra
    PubMed HealthAvanafil (By mouth)
    Drug ClassesErectile Dysfunction Agent
    Drug LabelSTENDRA (avanafil) is a selective inhibitor of cGMP-specific PDE5.Avanafil is designated chemically as (S)-4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide and has the following...
    Active IngredientAvanafil
    Dosage FormTablet
    RouteOral
    Strength200mg; 100mg; 50mg
    Market StatusPrescription
    CompanyVivus

    4.2 Drug Indication

    Avanafil is indicated for the treatment of erectile dysfunction.

    FDA Label

    Treatment of erectile dysfunction in adult men.

    In order for Spedra to be effective, sexual stimulation is required.

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Avanafil is a strong competitive inhibitor of phosphodiesterase 5 (PDE5) with a demonstrated _in vitro_ IC50 of 5.2 nM. Its inhibitory effects on PDE5 are 100-fold more potent than on PDE6 and >1000-fold more potent than on other PDE enzymes, meaning it is less likely to cause visual disturbances and cardiovascular adverse effects when compared with less selective PDE5 inhibitors such as [sildenafil] and [vardenafil]. It has a relatively quick onset of action allowing for administration as early as 15 minutes prior to sexual activity. PDE5 inhibitors like avanafil can cause significant drug interactions when administered alongside certain antihypertensive agents (e.g. alpha blockers, substantial amounts of alcohol). PDE5 inhibitors have also been associated with the development of non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition that typically presents as sudden loss of vision in one or both eyes and appears to be more common in patients with a "crowded" optic disc. Patients presenting with any degree of vision loss should immediately discontinue use of all PDE5 inhibitors and seek medical attention. In some jurisdictions, a history of NAION or other degenerative retinal disorders is considered a contraindication to avanafil therapy.

    5.2 FDA Pharmacological Classification
    5.2.1 Active Moiety
    AVANAFIL
    5.2.2 FDA UNII
    DR5S136IVO
    5.2.3 Pharmacological Classes
    Phosphodiesterase 5 Inhibitors [MoA]; Phosphodiesterase 5 Inhibitor [EPC]
    5.3 ATC Code

    G04BE10

    G04BE10

    S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355

    G - Genito urinary system and sex hormones

    G04 - Urologicals

    G04B - Urologicals

    G04BE - Drugs used in erectile dysfunction

    G04BE10 - Avanafil

    5.4 Absorption, Distribution and Excretion

    Absorption

    Avanafil is rapidly absorbed following oral administration (Tmax of 30-45 minutes) and appears to have low to moderate oral bioavailability, though formal studies have not been conducted. Administration with a meal results in a mean delay in Tmax of 1.12 to 1.25 hours, a 39% mean reduction in Cmax, and a negligible effect on AUC.

    Route of Elimination

    Following oral administration, avanafil is extensively metabolized. Approximately 62% of a given dose is excreted as metabolites in the feces and approximately 21% as metabolites in the urine.

    Volume of Distribution

    The apparent volume of distribution of avanafil is 47 to 83 L.

    5.5 Metabolism/Metabolites

    Avanafil is extensively metabolized, primarily by CYP3A4 and to a lesser extent by CYP2C9. There are two major metabolites formed, M4 and M16, which exist in the plasma at concentrations 23% and 29% that of the parent compound, respectively. The M16 metabolite lacks pharmacologic effect, but the M4 metabolite has an inhibitory potency for PDE5 18% that of avanafil and accounts for approximately 4% of the observed pharmacologic activity of avanafil.

    5.6 Biological Half-Life

    Studies have demonstrated variability in the terminal elimination half-life of avanafil, with estimates ranging between 5 - 17 hours.

    5.7 Mechanism of Action

    Avanafil inhibits the cGMP-specific phosphodiesterase type 5 (PDE5) which is responsible for the degradation of cGMP in the corpus cavernosum located around the penis. Sexual arousal results in the local release of nitric oxide, which in turn stimulates the enzyme guanylate cyclase to produce cGMP. Elevated levels of cGMP result in local smooth muscle relaxation and increased blood flow to the penis (i.e. an erection). As PDE5 inhibitors like avanafil require the endogenous release of nitric oxide in order to exert their pharmacologic effect, they have no effect on the user in the absence of sexual stimulation/arousal.

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"AVANAFIL","year":"2021","qtr":"Q1","strtotime":1609871400,"product":"AVANAFIL(TAX INV NO.G2103SE-352 DT.21.12","address":"PLOT NO. 7314\/8, M\/S KOHINOOR METAL GIDC ESTATE","city":"ANKLESHWAR , DIST BHARUCH, GUJARAT","supplier":"SKJ PHARMACHEM","supplierCountry":"INDIA","foreign_port":"BEIRUT","customer":"TO THE ORDER OF","customerCountry":"LEBANON","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"1495","totalValueFC":"1463","currency":"USD","unitRateINR":107000,"date":"06-Jan-2021","totalValueINR":"107000","totalValueInUsd":"1463","indian_port":"AHMEDABAD AIR","hs_no":"29335990","bill_no":"7727946","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"LEBANON","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"PLOT NO. 7314\/8, M\/S KOHINOOR METAL GIDC ESTATE, ANKLESHWAR , DIST BHARUCH, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"AVANAFIL","year":"2021","qtr":"Q1","strtotime":1609957800,"product":"AVANAFIL(TAX INV NO.G2103SE-352 DT.21.12 .2020) GST NO.37AACCH8413M3Z8","address":"PLOT NO. 7314\/8, M\/S KOHINOOR METAL GIDC ESTATE","city":"ANKLESHWAR , DIST BHARUCH, GUJARAT","supplier":"SKJ PHARMACHEM","supplierCountry":"INDIA","foreign_port":"BEIRUT","customer":"TO THE ORDER OF","customerCountry":"LEBANON","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"1449.1","totalValueFC":"1467.2","currency":"USD","unitRateINR":107308.96000000001,"date":"07-Jan-2021","totalValueINR":"107308.96","totalValueInUsd":"1467.2","indian_port":"AHMEDABAD AIR","hs_no":"29335990","bill_no":"7746597","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"LEBANON","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"PLOT NO. 7314\/8, M\/S KOHINOOR METAL GIDC ESTATE, ANKLESHWAR , DIST BHARUCH, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1626633000,"product":"AVANAFIL","address":"425\/3 RT D NO 7-1-621\/328,S.R.NAGAR","city":"HYDERABAD.AP","supplier":"RAKSHIT PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"M\/S.","customerCountry":"EGYPT","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"1378.9","totalValueFC":"5332.2","currency":"USD","unitRateINR":99348,"date":"19-Jul-2021","totalValueINR":"397392","totalValueInUsd":"5332.2","indian_port":"HYDERABAD AIR","hs_no":"29321990","bill_no":"3227366","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"425\/3 RT D NO 7-1-621\/328,S.R.NAGAR, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1630261800,"product":"AVANAFIL (TAX INV NO:1900215576 DT:24.08 .2021)","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"GULF AGENCY COMPANY ","customerCountry":"UNITED ARAB EMIRATES","quantity":"0.60","actualQuantity":"0.6","unit":"KGS","unitRateFc":"4912.8","totalValueFC":"2863.5","currency":"USD","unitRateINR":353965,"date":"30-Aug-2021","totalValueINR":"212379","totalValueInUsd":"2863.5","indian_port":"HYDERABAD AIR","hs_no":"29334900","bill_no":"4233299","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1634841000,"product":"AVANAFIL","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"HAMBURG","customer":"I CARGO INTERNATIONALE LOGISTIC & HANDELS GMBH","customerCountry":"GERMANY","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"3179.2","totalValueFC":"31426.5","currency":"USD","unitRateINR":235422.5,"date":"22-Oct-2021","totalValueINR":"2354225","totalValueInUsd":"31426.5","indian_port":"Vizag-HIPL SEZ","hs_no":"29335990","bill_no":"4000782","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1635791400,"product":"AVANAFIL","address":"425\/3 RT D NO 7-1-621\/328,S.R.NAGAR","city":"HYDERABAD.AP","supplier":"RAKSHIT PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"BEIRUT","customer":"TO THE ORDER OF","customerCountry":"LEBANON","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"1400","totalValueFC":"13871.1","currency":"USD","unitRateINR":103300,"date":"02-Nov-2021","totalValueINR":"1033000","totalValueInUsd":"13871.1","indian_port":"HYDERABAD AIR","hs_no":"29321990","bill_no":"5769075","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"LEBANON","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"425\/3 RT D NO 7-1-621\/328,S.R.NAGAR, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1638815400,"product":"AVANAFIL","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"JEDDAH","customer":"JAMJOOM PHARMACEUTICALS COMPANY","customerCountry":"SAUDI ARABIA","quantity":"110.00","actualQuantity":"110","unit":"KGS","unitRateFc":"1395.4","totalValueFC":"150995.5","currency":"USD","unitRateINR":103536.42727272728,"date":"07-Dec-2021","totalValueINR":"11389007","totalValueInUsd":"150995.5","indian_port":"Vizag-HIPL SEZ","hs_no":"29335990","bill_no":"4000876","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SAUDI ARABIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1639161000,"product":"AVANAFIL","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"MILAN","customer":"NICOX RESEARCH INSTITUTE SRL","customerCountry":"ITALY","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"5000","totalValueFC":"967.8","currency":"USD","unitRateINR":365000,"date":"11-Dec-2021","totalValueINR":"73000","totalValueInUsd":"967.8","indian_port":"HYDERABAD AIR","hs_no":"29334900","bill_no":"6670430","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648060200,"product":"AVANAFIL","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"GUANGZHOU TOSUN PHARMACEUTICAL","customerCountry":"CHINA","quantity":"8.00","actualQuantity":"8","unit":"KGS","unitRateFc":"2990.4","totalValueFC":"23603.5","currency":"USD","unitRateINR":224880.5,"date":"24-Mar-2022","totalValueINR":"1799044","totalValueInUsd":"23603.5","indian_port":"Vizag-HIPL SEZ","hs_no":"29335990","bill_no":"4000224","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1668623400,"product":"AVANAFIL","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"JEDDAH","customer":"BATTERJEE PHARMACEUTICAL FACTORY","customerCountry":"SAUDI ARABIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"2191.6","totalValueFC":"11023.4","currency":"USD","unitRateINR":179929.20000000001,"date":"17-Nov-2022","totalValueINR":"899646","totalValueInUsd":"11023.4","indian_port":"Vizag-HIPL SEZ","hs_no":"29339990","bill_no":"4000825","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SAUDI ARABIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1674757800,"product":"MSN PHARMACEUTICAL PRODUCT NAME AVANAFIL","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"RIYADH","customer":"TO THE ORDER OF","customerCountry":"SAUDI ARABIA","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"3000","totalValueFC":"147371.3","currency":"USD","unitRateINR":240980,"date":"27-Jan-2023","totalValueINR":"12049000","totalValueInUsd":"147371.3","indian_port":"HYDERABAD AIR","hs_no":"29334900","bill_no":"7291497","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SAUDI ARABIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676917800,"product":"AVANAFIL","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"HAMBURG","customer":"ALDER TRADING FZ LLC","customerCountry":"GERMANY","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"3092.8","totalValueFC":"30669.3","currency":"USD","unitRateINR":253297.79999999999,"date":"21-Feb-2023","totalValueINR":"2532978","totalValueInUsd":"30669.3","indian_port":"Vizag-HIPL SEZ","hs_no":"29339990","bill_no":"4000129","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1683311400,"product":"NON HAZARDOUS PHARMACEUTICAL RAW MATERIAL AVANAFIL","address":"425\/3 RT D NO 7-1-621\/328, S.R.NAGAR Contact No: 919177739734","city":"HYDERABAD","supplier":"RAKSHIT PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"THE HSBC LTD","customerCountry":"BANGLADESH","quantity":"26.00","actualQuantity":"26","unit":"KGS","unitRateFc":"1300","totalValueFC":"33177.7","currency":"USD","unitRateINR":105000,"date":"06-May-2023","totalValueINR":"2730000","totalValueInUsd":"33177.7","indian_port":"HYDERABAD AIR","hs_no":"29321990","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"425\/3 RT D NO 7-1-621\/328, S.R.NAGAR Contact No: 919177739734, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1684002600,"product":"MSN PHARMACEUTICAL PRODUCT NAME AVANAFIL","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"TO THE ORDER","customerCountry":"UNITED ARAB EMIRATES","quantity":"18.50","actualQuantity":"18.5","unit":"KGS","unitRateFc":"4455","totalValueFC":"80744.5","currency":"USD","unitRateINR":359135.13513513515,"date":"14-May-2023","totalValueINR":"6644000","totalValueInUsd":"80744.5","indian_port":"HYDERABAD AIR","hs_no":"29334900","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1707330600,"product":"AVANAFIL","address":"425\/3 RT D NO 7-1-621\/328,","city":"HYDERABAD.AP","supplier":"RAKSHIT PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"ASUNCION","customer":"LABORATORIOS GALENO S.A.","customerCountry":"PARAGUAY","quantity":"16.00","actualQuantity":"16","unit":"KGS","unitRateFc":"1830","totalValueFC":"28547.8","currency":"USD","unitRateINR":148044.75,"date":"08-Feb-2024","totalValueINR":"2368716","totalValueInUsd":"28547.8","indian_port":"Hyderabad Air","hs_no":"29321990","bill_no":"7374739","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PARAGUAY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"425\/3 RT D NO 7-1-621\/328,, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1717439400,"product":"AVANAFIL","address":"425\/3 RT D NO 7-1-621\/328,","city":"HYDERABAD.AP","supplier":"RAKSHIT PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"HANOI - NOIBAI","customer":"VINH PHUC PHARMACEUTICAL ","customerCountry":"VIETNAM","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"2050","totalValueFC":"1916.8","currency":"USD","unitRateINR":160013.5,"date":"04-Jun-2024","totalValueINR":"160013.5","totalValueInUsd":"1916.8","indian_port":"Hyderabad Air","hs_no":"29321990","bill_no":"1415462","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"VIETNAM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"425\/3 RT D NO 7-1-621\/328,, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720722600,"product":"AVANAFIL","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SANTIAGO DE CHILE -","customer":"LABORATORIES RECALCINE SA","customerCountry":"CHILE","quantity":"13.00","actualQuantity":"13","unit":"KGS","unitRateFc":"4500","totalValueFC":"57876.4","currency":"USD","unitRateINR":372150,"date":"12-Jul-2024","totalValueINR":"4837950","totalValueInUsd":"57876.4","indian_port":"Hyderabad Air","hs_no":"29334900","bill_no":"2374592","productDescription":"API","marketType":"REGULATED MARKET","country":"CHILE","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720722600,"product":"AVANAFIL","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"HO CHI MINH C","customer":"PHONG PHU PHARMACEUTICAL ","customerCountry":"VIETNAM","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"2800","totalValueFC":"13804.9","currency":"USD","unitRateINR":230793.60000000001,"date":"12-Jul-2024","totalValueINR":"1153968","totalValueInUsd":"13804.9","indian_port":"Hyderabad Air","hs_no":"29334900","bill_no":"2379684","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"VIETNAM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723573800,"product":"AVANAFIL","address":"425\/3 RT D NO 7-1-621\/328,","city":"HYDERABAD.AP","supplier":"RAKSHIT PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"STANDARD CHARTERED BANK.","customerCountry":"BANGLADESH","quantity":"30.00","actualQuantity":"30","unit":"KGS","unitRateFc":"1300","totalValueFC":"38414.5","currency":"USD","unitRateINR":107405,"date":"14-Aug-2024","totalValueINR":"3222150","totalValueInUsd":"38414.5","indian_port":"Hyderabad Air","hs_no":"29321990","bill_no":"3209241","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"425\/3 RT D NO 7-1-621\/328,, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732213800,"product":"AVANAFIL","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"TAOYUAN","customer":"ZALOZA INTERNATIONAL CO ","customerCountry":"TAIWAN","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"3000","totalValueFC":"8867.2","currency":"USD","unitRateINR":249429.66666666666,"date":"22-Nov-2024","totalValueINR":"748289","totalValueInUsd":"8867.2","indian_port":"Vizag-HIPL SEZ","hs_no":"29339990","bill_no":"5829810","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""}]
    06-Jan-2021
    22-Nov-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API/FDF Prices: Book a Demo to explore the features and consider upgrading later

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    DRUG PRODUCT COMPOSITIONS

    Do you need Business Intel? Ask us

    DOSAGE - TABLET;ORAL - 100MG

    USFDA APPLICATION NUMBER - 202276

    read-more

    DOSAGE - TABLET;ORAL - 200MG

    USFDA APPLICATION NUMBER - 202276

    read-more

    DOSAGE - TABLET;ORAL - 50MG

    USFDA APPLICATION NUMBER - 202276

    read-more

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Granulation

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Looking for 330784-47-9 / Avanafil API manufacturers, exporters & distributors?

    Avanafil manufacturers, exporters & distributors 1

    54

    PharmaCompass offers a list of Avanafil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Avanafil manufacturer or Avanafil supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Avanafil manufacturer or Avanafil supplier.

    PharmaCompass also assists you with knowing the Avanafil API Price utilized in the formulation of products. Avanafil API Price is not always fixed or binding as the Avanafil Price is obtained through a variety of data sources. The Avanafil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

    API | Excipient name

    Avanafil

    Synonyms

    330784-47-9, Stendra, Spedra, Ta 1790, Ta-1790, (s)-4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-n-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide

    Cas Number

    330784-47-9

    Unique Ingredient Identifier (UNII)

    DR5S136IVO

    About Avanafil

    Avanafil is an orally available phosphodiesterase type 5 (PDE5) inhibitor with vasodilatory activity. Avanafil selectively inhibits PDE5, thus inhibiting the degradation of cyclic guanosine monophosphate (cGMP) found in the smooth muscle of the corpus cavernosa of the penis. The inhibition of cGMP degradation results in prolonged muscle relaxation, vasodilation, and blood engorgement of the corpus cavernosa, thereby prolonging penile erection.

    Avanafil Manufacturers

    A Avanafil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Avanafil, including repackagers and relabelers. The FDA regulates Avanafil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Avanafil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Avanafil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Avanafil Suppliers

    A Avanafil supplier is an individual or a company that provides Avanafil active pharmaceutical ingredient (API) or Avanafil finished formulations upon request. The Avanafil suppliers may include Avanafil API manufacturers, exporters, distributors and traders.

    click here to find a list of Avanafil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Avanafil USDMF

    A Avanafil DMF (Drug Master File) is a document detailing the whole manufacturing process of Avanafil active pharmaceutical ingredient (API) in detail. Different forms of Avanafil DMFs exist exist since differing nations have different regulations, such as Avanafil USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Avanafil DMF submitted to regulatory agencies in the US is known as a USDMF. Avanafil USDMF includes data on Avanafil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Avanafil USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Avanafil suppliers with USDMF on PharmaCompass.

    Avanafil KDMF

    In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

    Pharmaceutical companies submit a Avanafil Drug Master File in Korea (Avanafil KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Avanafil. The MFDS reviews the Avanafil KDMF as part of the drug registration process and uses the information provided in the Avanafil KDMF to evaluate the safety and efficacy of the drug.

    After submitting a Avanafil KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Avanafil API can apply through the Korea Drug Master File (KDMF).

    click here to find a list of Avanafil suppliers with KDMF on PharmaCompass.

    Avanafil WC

    A Avanafil written confirmation (Avanafil WC) is an official document issued by a regulatory agency to a Avanafil manufacturer, verifying that the manufacturing facility of a Avanafil active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Avanafil APIs or Avanafil finished pharmaceutical products to another nation, regulatory agencies frequently require a Avanafil WC (written confirmation) as part of the regulatory process.

    click here to find a list of Avanafil suppliers with Written Confirmation (WC) on PharmaCompass.

    Avanafil NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Avanafil as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Avanafil API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Avanafil as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Avanafil and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Avanafil NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Avanafil suppliers with NDC on PharmaCompass.

    Avanafil GMP

    Avanafil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Avanafil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Avanafil GMP manufacturer or Avanafil GMP API supplier for your needs.

    Avanafil CoA

    A Avanafil CoA (Certificate of Analysis) is a formal document that attests to Avanafil's compliance with Avanafil specifications and serves as a tool for batch-level quality control.

    Avanafil CoA mostly includes findings from lab analyses of a specific batch. For each Avanafil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Avanafil may be tested according to a variety of international standards, such as European Pharmacopoeia (Avanafil EP), Avanafil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Avanafil USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search